Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
trazodone hydrochloride (new polymer formulation)
- Development stage
- Unknown
- Lead developer
- Angelini Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Trazodone hydrochloride (new polymer formulation) is an extended-release, small molecule antidepressant being developed by Aziende Chimiche Riunite Angelini Francesco S.p.A (Angelini Group) for the treatment of major depressive disorder. This specific product utilizes a novel polymer-based controlled-release technology designed to optimize the pharmacokinetic profile of trazodone, distinguishing it from previous extended-release versions such as the Contramid-based formulation (marketed as Oleptro or Trittico). Trazodone acts as a serotonin antagonist and reuptake inhibitor (SARI), primarily functioning as an antagonist at the 5-HT2A and 5-HT2C receptors and as an inhibitor of the serotonin transporter (SERT). It also exhibits antagonistic activity at alpha-1 adrenergic and histamine H1 receptors, which contributes to its clinical profile. The new polymer formulation is currently undergoing Phase 1 clinical evaluation to establish its bioavailability and bioequivalence relative to existing once-a-day trazodone products.
- Other names
- trazodone hydrochloride (new polymer)trazodone OAD
02
Targets
ADRA1A (α1A)SERT (Sodium-dependent serotonin transporter)HRH1 (Histamine H1 Receptor)HTR2A (Serotonin receptor 5-HT2A)HTR2C (5-hydroxytryptamine 2C receptor)
Beyond the preview
Go deeper on trazodone hydrochloride (new polymer formulation).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on trazodone hydrochloride (new polymer formulation).